Evidence map›Paper›PMID 41431193›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Osmotic Tension Asymmetry Drives Electrotactic Migration via PDLIM7-Polarized Microfilament Coordination in Breast Cancer Cells.

Ling Zhu, Zihui Zheng, Wang Li, Chenyi Shou, Ying Zhao, Lijun Zhang, Xiaoli Shi, Yunfeng Hu, Huanhuan Zhao, Huiwen Wu and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ling ZhuState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Zihui ZhengState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Wang LiState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Chenyi ShouState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Ying ZhaoState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Lijun ZhangState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Xiaoli ShiState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Yunfeng HuState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Huanhuan ZhaoBasic Medical Experiment Center, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P. R. China.
Huiwen WuLaboratory Center for Basic Medical Sciences, Nanjing Medical University, Nanjing, P. R. China.
Jun GuoState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, P. R. China.ORCID https://orcid.org/0000-0002-8525-8267

Funding

Grants from the National Natural Science Foundation of China 82273908Innovation Projects of State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture NZYSKL240203Open Project of Chinese Materia Medica First-Class Discipline of Nanjing University of Chinese Medicine ZYXJC2024-005
6 · The paper itself

Abstract

Directional migration of tumor cells depends on mechanical forces generated by intracellular asymmetry. This study establishes an electric field-induced directional migration model using fluorescence tension probes to visualize microfilament forces and intracellular osmotic pressure dynamics. Electric fields induce protein kinase A (PKA)-dependent PDLIM7 recruitment, polarizing microfilament tension at cell edges via site-specific phosphorylation at serine 190. Concurrently, the electric field induces asymmetric changes in membrane potential, driven by protein nanoparticles and calcium ions, regulating osmotic tension. Leading-edge depolarization activates TMEM16A channel, while trailing-edge hyperpolarization activates the small conductance calcium-activated potassium (SK) channel. Chloride influx and potassium efflux create differential ion diffusion, resulting in leading-edge hypertonic expansion and trailing-edge contraction, thereby dictating the directionality of electrotactic migration. Osmotic pressure asymmetry further modulates PKA polarity, amplifying directional migration cues. This study elucidates the coordinated interplay between osmotic tension and membrane potential in cellular electromechanics, revealing a mechanistic framework where osmotic tension asymmetry orchestrates tumor cell migration through polarized PDLIM7-microfilament tension regulation.

Indexed as

Actin CytoskeletonAdaptor Proteins, Signal TransducingBreast NeoplasmsCell MovementLIM Domain ProteinsOsmotic PressureCell Line, TumorFemaleHumansAdaptor Proteins, Signal TransducingLIM Domain Proteinsbreast cancerdirectional migrationelectrotaxisosmotic pressure asymmetryPDLIM7

Identifiers

PMID41431193
PMCPMC12955868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.